Systems announces the appointment of Rob Parry as President and Chief Operating
Officer. Mr. Parry will be focused on expanding sales of the MAUI Microarray
Product Suite, as well as launching a new line of products for the cytogenetics
market. IGOR™, an "Automated Lab Assistant" for processing FISH,
WISH, Blots and other slide-based applications, will be available Fall 2009.
BioMicro Systems is a private company that serves the life sciences community
by developing and marketing biological research products based on its proprietary
microfluidic and microarray technologies.
Mr. Parry has been serving as Chief Operating Officer and Vice President of
Manufacturing at BioMicro Systems since February of 2007. Prior to BioMicro
Systems, Mr. Parry held top level manufacturing positions in several instrument
and consumable businesses, including Hewlett Packard, Agilent Technologies,
Fluidigm, and Nanosys. His innovative and effective leadership at BioMicro Systems
has led to ISO 9001 certification of the organization, and cost-effective manufacturing
processes with consistent high quality and availability of products. In addition
to his manufacturing responsibilities at BioMicro, Mr. Parry directed product
development efforts and is a co-inventor of both the new IGOR system as well
as the successful new design of the MAUI Wash System.
Mr. Parry added, "I am excited to take the lead of the BioMicro Systems
team. I see great near term opportunities for our new products and applications.
The IGOR system will be the Company's first medical device sold into the clinical
market, introducing the Company to a whole new customer base."
Mr. Parry received a B.S.M.E. from Cal Poly, San Luis Obispo, and an M.S. from
MIT in Operations Management and Technology Innovation.
Nanostart AG is the world’s leading nanotechnology investment company.
The Frankfurt-based company provides venture capital financing for nanotechnology
companies in various growth phases. It also provides the benefits of its experience
and expertise to developers of financial instruments and to investors in the
nanotechnology sector. For further information about the company, please visit
About BioMicro Systems, Inc.:
BioMicro Systems, Inc. is a private company focused on the development and commercialization
of biological research products based on its proprietary microfluidic and microarray
technologies. More company information can be found at www.biomicro.com.